亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Deprescribing benzodiazepine receptor agonists for insomnia in older adults

失眠症 苯二氮卓 斯科普斯 折旧 医学 谵妄 原发性失眠 生活质量(医疗保健) 精神科 梅德林 老年学 多药 受体 内科学 睡眠障碍 护理部 法学 政治学
作者
Antoine Christiaens,Carole E. Aubert,Adam Wichniak,Antoni Salvà,Anne Spinewine
出处
期刊:The Lancet [Elsevier BV]
卷期号:402 (10411): 1421-1422
标识
DOI:10.1016/s0140-6736(23)01562-3
摘要

The Series paper on insomnia by Michael Perlis and colleagues1Perlis ML Posner D Riemann D Bastien CH Teel J Thase M Insomnia.Lancet. 2022; 400: 1047-1060Summary Full Text Full Text PDF PubMed Scopus (54) Google Scholar summarises evidence on the diagnosis and management of insomnia, but overlooks important considerations on the management of insomnia in older adults. Although the authors highlight that evidence on the efficacy of pharmacological approaches in older people, including benzodiazepine receptor agonists (BZRAs), is of low quality, they also emphasise that BZRAs are an appropriate option when cognitive behavioural therapy for insomnia is not effective or available. This statement should be reconsidered when it comes to older adults. First, the use of BZRAs is associated with major risks not mentioned by the authors, such as falls, fractures, delirium, impaired functioning, hospitalisations, and mortality,2Chatterjee D Iliffe S Kharicha K et al.Health risk appraisal in older people 7: long-acting benzodiazepine use in community-dwelling older adults in London: is it related to physical or psychological factors?.Prim Health Care Res Dev. 2017; 18: 253-260Crossref Scopus (6) Google Scholar burdening both patients and society.3Panneman MJ Goettsch WG Kramarz P Herings RM The costs of benzodiazepine-associated hospital-treated fall injuries in the EU: a Pharmo study.Drugs Aging. 2003; 20: 833-839Crossref PubMed Scopus (71) Google Scholar Second, international groups have made strong recommendations against the use of BZRAs in older adults, or recommendations to use them only short term (typically up to 4 weeks for the treatment of insomnia). Yet, BZRA overuse is one of the most prevalent and harmful overuse practices in older adults.4OECDHealth at a Glance 2019: OECD Indicators. OECD Publishers, Paris2019Crossref Google Scholar Deprescribing guidelines recommend to consider deprescribing in older adults taking a BZRA for insomnia.5Pottie K Thompson W Davies S et al.Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline.Can Fam Physician. 2018; 64: 339-351PubMed Google Scholar Such recommendations should ideally be integrated into the guidelines on the management of insomnia. Better addressing patients’ and health-care professionals’ barriers to BZRA deprescribing is also essential.6Evrard P Petein C Beuscart JB Spinewine A Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.Implement Sci. 2022; 17: 41Crossref Scopus (16) Google Scholar Beyond the authors’ call for further research on new therapeutic approaches, we need further research on the effectiveness of theory-driven implementation approaches and a cultural change that promotes de-implementing potentially harmful strategies into the routine management of insomnia for older people. We declare no competing interests. The authors of this Correspondence are all partners of the Implementing a patient-centred and evidence-based intervention to reduce BEnzodiazepine and sedative-hypnotic use to improve patient SAFEty and quality of care (BE-SAFE) project, funded by the EU (Horizon Europe research and innovation programme, grant agreement 101057123) and by the Swiss State Secretariat for Education, Research and Innovation (SERI; contract number 22.00116). Views and opinions expressed are, however, those of the authors only and do not necessarily reflect those of the EU or SERI. Neither the EU nor SERI can be held responsible for them. The funders of the study had no role in writing this Correspondence. InsomniaInsomnia is highly prevalent in clinical practice, occurring in up to 50% of primary care patients. Insomnia can present independently or alongside other medical conditions or mental health disorders and is a risk factor for the development and exacerbation of these other disorders if not treated. In 2016, the American College of Physicians recommended that insomnia be specifically targeted for treatment. The recommended first-line treatment for insomnia, whether the underlying cause has been identified or not, is cognitive behavioural therapy for insomnia (CBT-I). Full-Text PDF

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ZT1发布了新的文献求助10
1秒前
amiee发布了新的文献求助10
2秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
3秒前
Nole的应助被科研通管家采纳,获得10
3秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
3秒前
3秒前
Nole的应助被科研通管家采纳,获得10
3秒前
Nole的应助被科研通管家采纳,获得10
3秒前
852的应助被科研通管家采纳,获得10
3秒前
4秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
4秒前
4秒前
6秒前
7秒前
乐乐的应助被zhangzhang采纳,获得10
7秒前
娜娜米发布了新的文献求助80
9秒前
沧海云帆发布了新的文献求助10
11秒前
12秒前
14秒前
15秒前
pzh完成签到 ,获得积分10
17秒前
19秒前
22秒前
29秒前
笨笨的青完成签到 ,获得积分10
29秒前
冷酷的飞绿完成签到 ,获得积分10
29秒前
Crssss的应助被优雅的黄豆采纳,获得10
29秒前
29秒前
小二郎的应助被娜娜米采纳,获得10
31秒前
张唤发布了新的文献求助10
33秒前
尊敬的之瑶完成签到,获得积分20
33秒前
科研通AI2S的应助被葵花街37号采纳,获得10
37秒前
科研通AI65的应助被萧雨墨采纳,获得10
40秒前
雪白的龙猫完成签到 ,获得积分10
43秒前
武陵人完成签到 ,获得积分10
44秒前
44秒前
嘻嘻哈哈的应助被张唤采纳,获得10
45秒前
花海发布了新的文献求助100
45秒前
53秒前
55秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190049
求助须知:如何正确求助?哪些是违规求助? 9577165
关于积分的说明 21851842
捐赠科研通 7788131
什么是DOI,文献DOI怎么找? 3436227
关于科研通互助平台的介绍 2559910
邀请新用户注册赠送积分活动 2482768